PK-PD relationship of the effects of argatroban on haemostasis in healthy young volunteers.

被引：1
|
作者：
Garrigou, D
Dubruc, C
Thuillez, C
Bergougnan, L
Thenot, JP
机构：
[1] Synthelabo Rech, Chilly Mazarin, France
[2] CHU Rouen, Serv Pharmacol Clin, Rouen, France
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80136-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII18
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [41] Pk-pd relationship of levodopa in different groups of patients with Parkinsons disease.
    Harder, S
    Baas, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 198 - 198
  • [42] Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations
    Krzyzanski, Wojciech
    Wiczling, Pawel
    Lowe, Phil
    Pigeolet, Etienne
    Fink, Martin
    Berghout, Alexander
    Balser, Sigrid
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 101S - 112S
  • [43] PK-PD modeling of cetrorelix effects on circadian testosterone production.
    Derendorf, H
    Hermann, R
    Romeis, P
    Locher, M
    Schnaars, Y
    Riethmüller-Winzen, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 156 - 156
  • [44] Pharmacokinetics (PK) and pharmacodynamics (PD) of orally (PO) administered midazolam (MDZ) in the presence and absence of intravenous (IV) flumazenil (F) in healthy volunteers.
    Lawendy, NM
    Holt, JL
    Fullerton, T
    Nafziger, AN
    Snyder, PJ
    Victory, J
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P15 - P15
  • [45] The pharmacokinetics (PK) and pharmacodynamics (PD) of VX-702, a novel, oral p38MAP kinase inhibitor, in healthy volunteers.
    Godfrey, C
    Mohanlal, R
    Merica, E
    Ette, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P52 - P52
  • [46] Residual effects of hypnotics on electroencephalographic paterns (EEGP) of healthy volunteers.
    Vera, F
    Navarro, JF
    Luna-Villegas, G
    Fernández-Mas, R
    Fernández-Guardiola, A
    SALUD MENTAL, 2000, 23 (02) : 31 - 35
  • [47] Effects of Safflor Yellow on the platelet aggregation and hemorrheology in healthy volunteers.
    Han, B
    Yu, X
    Li, G
    Fu, F
    Zhang, L
    Zhu, M
    Yu, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P62 - P62
  • [48] PK/PD modeling of the effects of morphine-6-β-glucuronide on pupil size in healthy volunteers
    Skarke, C
    Geisslinger, G
    Lötsch, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R119 - R119
  • [49] Pharmacokinetics and pharmacodynamics of PD 0200390 following single dose administration to healthy volunteers.
    Corrigan, B. W.
    Werth, J.
    Bramson, C.
    Alvey, C.
    Abel, R.
    Feltner, D.
    Ouellet, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S29 - S29
  • [50] THE EFFECTS OF REPEATED LOW DOSES OF LSD IN HEALTHY HUMAN VOLUNTEERS.
    Molla, H.
    Bershad, A.
    Bremmer, M.
    Lee, R.
    de Wit, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S37 - S37
12345